Literature DB >> 2673470

Pulmonary surfactant: physiology, pharmacology and clinical uses.

N S Morton1.   

Abstract

The endogenous surfactant system in the lungs is complex. The synthetic, recycling and metabolic pathways are clear but the controlling mechanisms are not fully understood. Surfactant-specific proteins are important and their isolation and manufacture opens up new prospects for production of a synthetic surfactant with all the properties of natural human surfactant for therapy and prophylaxis of neonatal respiratory distress syndrome.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2673470

Source DB:  PubMed          Journal:  Br J Hosp Med        ISSN: 0007-1064


  4 in total

1.  Exogenous surfactant treatment for the adult respiratory distress syndrome? A historical perspective.

Authors:  N S Morton
Journal:  Thorax       Date:  1990-11       Impact factor: 9.139

2.  Therapeutic use of surfactant in neonatal respiratory distress syndrome. Correlation between pulmonary X-ray changes and clinical data.

Authors:  U Bick; C Müller-Leisse; J Tröger; G Jorch; N Roos; J Meyer zu Wendischhoff; U Flothmann; W Kachel; P Lemburg; O Linderkamp
Journal:  Pediatr Radiol       Date:  1992

3.  In Vitro Investigations of Human Bioaccessibility from Reference Materials Using Simulated Lung Fluids.

Authors:  Aurélie Pelfrêne; Mark R Cave; Joanna Wragg; Francis Douay
Journal:  Int J Environ Res Public Health       Date:  2017-01-24       Impact factor: 3.390

Review 4.  The surfactant system of the adult lung: physiology and clinical perspectives.

Authors:  H Hamm; H Fabel; W Bartsch
Journal:  Clin Investig       Date:  1992-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.